Evidence map›Paper›PMID 40179369›Full record

ArticleJournal of medical Internet research2025

Investigating Measurement Equivalence of Smartphone Sensor-Based Assessments: Remote, Digital, Bring-Your-Own-Device Study.

Lito Kriara, Frank Dondelinger, Luca Capezzuto, Corrado Bernasconi, Florian Lipsmeier, Adriano Galati, Michael Lindemann

Abstract read
In one paragraph

Article in Journal of medical Internet research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Lito KriaraF. Hoffmann-La Roche Ltd, Basel, Switzerland.ORCID 0000-0002-9159-0469
Frank DondelingerF. Hoffmann-La Roche Ltd, Basel, Switzerland.ORCID 0000-0003-1816-6300
Luca CapezzutoF. Hoffmann-La Roche Ltd, Basel, Switzerland.ORCID 0000-0002-2186-2406
Corrado BernasconiF. Hoffmann-La Roche Ltd, Basel, Switzerland.ORCID 0000-0002-1019-5468
Florian LipsmeierF. Hoffmann-La Roche Ltd, Basel, Switzerland.ORCID 0000-0002-8663-819X
Adriano GalatiF. Hoffmann-La Roche Ltd, Basel, Switzerland.ORCID 0009-0006-9661-899X
Michael LindemannF. Hoffmann-La Roche Ltd, Basel, Switzerland.ORCID 0000-0003-1010-3890

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFloodlight Open is a global, open-access, fully remote, digital-only study designed to understand the drivers and barriers in deployment and persistence of use of a smartphone app for measuring functional impairment in a naturalistic setting and broad study population.

objectiveThis study aims to assess measurement equivalence properties of the Floodlight Open app across operating system (OS) platforms, OS versions, and smartphone device models.

methodsFloodlight Open enrolled adult participants with and without self-declared multiple sclerosis (MS). The study used the Floodlight Open app, a "bring-your-own-device" (BYOD) solution that remotely measured MS-related functional ability via smartphone sensor-based active tests. Measurement equivalence was assessed in all evaluable participants by comparing the performance on the 6 active tests (ie, tests requiring active input from the user) included in the app across OS platforms (iOS vs Android), OS versions (iOS versions 11-15 and separately Android versions 8-10; comparing each OS version with the other OS versions pooled together), and device models (comparing each device model with all remaining device models pooled together). The tests in scope were Information Processing Speed, Information Processing Speed Digit-Digit (measuring reaction speed), Pinching Test (PT), Static Balance Test, U-Turn Test, and 2-Minute Walk Test. Group differences were assessed by permutation test for the mean difference after adjusting for age, sex, and self-declared MS disease status.

resultsOverall, 1976 participants using 206 different device models were included in the analysis. Differences in test performance between subgroups were very small or small, with percent differences generally being ≤5% on the Information Processing Speed, Information Processing Speed Digit-Digit, U-Turn Test, and 2-Minute Walk Test; <20% on the PT; and <30% on the Static Balance Test. No statistically significant differences were observed between OS platforms other than on the PT (P<.001). Similarly, differences across iOS or Android versions were nonsignificant after correcting for multiple comparisons using false discovery rate correction (all adjusted P>.05). Comparing the different device models revealed a statistically significant difference only on the PT for 4 out of 17 models (adjusted P≤.001-.03).

conclusionsConsistent with the hypothesis that smartphone sensor-based measurements obtained with different devices are equivalent, this study showed no evidence of a systematic lack of measurement equivalence across OS platforms, OS versions, and device models on 6 active tests included in the Floodlight Open app. These results are compatible with the use of smartphone-based tests in a bring-your-own-device setting, but more formal tests of equivalence would be needed.

Indexed as

Mobile ApplicationsMultiple SclerosisSmartphoneAdultFemaleHumansMaleMiddle Agedautoimmune diseasebalancecognitiondevice equivalencedigital assessmentdigital biomarkerdigital healthequivalenceFloodlight Opengaithand motor functionmHealthmobile healthmobile phonemotormultiple sclerosissensorssmartphoneupper extremity functionvariabilitywearable electronic devices

Identifiers

PMID40179369
PMCPMC12006779

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.